Alias: Femara
Pureza: 99%min
Número de registro CAS: 112809-51-5
Fórmula molecular: C17H11N5
Peso molecular: 285.3
Nota: Grau Farmacêutico
Uso: material farmacêutico
Femara, sold under the brand name Femara, is a prescription drug used to treat breast cancer in its advanced stages, and in women who have finished menopause. Doctors may use Femara off-label in fertility treatments to help encourage egg release (ovulation) in women. Femara belongs to a class of cancer drugs known as aromatase inhibitors, which work by preventing the body from converting a hormone called androgen into estrogen.
Letrozole is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer.
For pre-contest bodybuilders, Letrozole is almost a necessity to eliminate water retention and achieve the ripped look necessary to compete in today’s bodybuilding world.
| ITENS DE TESTE |
ESPECIFICAÇÃO
|
RESULTADOS
|
|
Descrição
|
Pó Cristalino Branco
|
Pó Branco
|
|
Identificação
|
Positivo
|
Positivo
|
|
Ensaio(por HPLC)
|
98.0~102,0%
|
99.58%
|
|
Absorbance(E1cm)
|
465~495
|
486.5
|
|
Ponto de fusão
|
191~195ºC
|
192.5~195.0ºC
|
|
Perda na secagem
|
0.5%máx.
|
0.22%
|
|
Rotação Específica
|
+288º~ +298º
|
+295.2ºC
|
|
Resíduos na ignição
|
0.1%máx.
|
0.02%
|
|
Substâncias Relacionadas
|
Total:1.5%máx.
|
<1.2%
|
|
|
Solteiro:0.5%máx.
|
<0.6%
|
|
Residue Solvents
|
0.2%máx.
|
0.1%
|
|
Metais Pesados
|
20PPm máx.
|
<10PPm
|
